You searched for metabolic diseases - Page 54 of 63

Best in Biotech 25 Apr 2024

8 of the most expensive drugs in biopharma: Unraveling the costliest medications

…in 2023 compared to the previous year, reflecting in part the industry’s embrace of expensive therapies for rare diseases like muscular dystrophy. Gene therapies in particular have emerged as some…

April 25, 2024 - 12 minutesmins - By Willow Shah-Neville

In Depth 6 Feb 2023

The biggest private biotech investments in January 2023

…help of biomaterials. Meanwhile, the U.S.-Chinese firm Structure Therapeutics went public on the Nasdaq raising $161.1 million to fund the development of oral treatments for chronic metabolic and pulmonary diseases….

February 6, 2023 - 4 minutesmins - By Jonathan Smith

News and Trends 9 Jun 2023

Med-Life Discoveries to start rare pediatric disease trial

…lead compound PPI-1011. This is a milestone on the path towards a potential therapy for children with RCDP. Med-Life Discoveries’ focus is the development of plasmalogen therapeutics for complex diseases…

June 9, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 1 Nov 2022

Pancreatic cancer could be diagnosed years earlier

…in weight and increase in blood glucose could be detected in patients’ years in advance of them receiving a diagnosis for pancreatic cancer. This makes these metabolic changes important candidates…

November 1, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 10 Apr 2017

Swiss-Danish Collaboration will use Synbio to Produce a B Vitamin

Two startups in the fields of synthetic biology, Biosyntia and FGen, have struck a partnership to identify promising microbial strains. The objective is to find a strain that enables bioproduction…

April 10, 2017 - 2 minutesmins - By Denise Neves Gameiro

Kurma Partner biotech investment rare diseases

News and Trends 30 Apr 2020

Update: Kurma Partners’ Third Biofund Closes at €160M

…for new commercial enterprises with a focus on rare diseases but, with this fund, we open the investment to other indications like oncology, metabolic, central nervous system and cardiovascular,” Droller…

April 30, 2020 - 2 minutesmins - By Jonathan Smith

clostridium difficile microbiomics seres health therapeutics nestle science crohns ibd uc cdi

News and Trends 12 Jan 2016

Microbiomics and Nestlé: €1.7Bn for New TransAtlantic Drug Development Program

Microbiomics is a hot area for biotech. Now US Seres Therapeutics and Nestlé Health Sciences have signed a massive drug development deal for bowel diseases and C.difficile infections. By correcting…

January 12, 2016 - 3 minutesmins - By Dani Bancroft

Best in Biotech 9 Mar 2023

5 advancements in kidney disease research over the past year

Prevalent in millions of people across the globe, kidney diseases manifest through various symptoms like blood and excess protein in urine, fluid retention causing swollen ankles, poor appetite and even…

March 9, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 10 Apr 2018

New Skin Care Products Use Plant Pigment Made By Bacteria

…company used a metabolic and fermentation engineering platform to adapt the bacterial strain to produce phytoene on an industrial scale. Using biological methods to produce cosmetic products seems to be…

April 10, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 14 Jul 2022

Agomab bags $114 million in thriving regenerative medicine sector

…the emerging field of regenerative medicine is coming to the fore. Agomab has embarked on an ambitious path to redefine how we understand regenerative medicine and tackle metabolic, inflammatory and…

July 14, 2022 - 3 minutesmins - By Victor Kotsev

In Depth 27 Jul 2022

The race to uncloak cancer with liquid biopsies

…even metabolic state. “Reading the genome architecture using EpiSwitch proves to be much less noisy compared to other biomarker modalities, which include continuous ranges of readouts and stochastic noise, thus…

July 27, 2022 - 10 minutesmins - By Editorial Team

News and Trends 27 Apr 2020

Series A Round Boosts Swedish Synthetic Biology Player by €6.4M

…the relevant enzymes and immobilizes them to its specially engineered material EziG so that metabolic pathways can continue outside of the cell. EnginZyme’s technique not only eliminates the cost of…

April 27, 2020 - 4 minutesmins - By Karen O’Hanlon Cohrt

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

8 of the most expensive drugs in biopharma: Unraveling the costliest medications

The biggest private biotech investments in January 2023

Med-Life Discoveries to start rare pediatric disease trial

Pancreatic cancer could be diagnosed years earlier

Swiss-Danish Collaboration will use Synbio to Produce a B Vitamin

Update: Kurma Partners’ Third Biofund Closes at €160M

Microbiomics and Nestlé: €1.7Bn for New TransAtlantic Drug Development Program

5 advancements in kidney disease research over the past year

New Skin Care Products Use Plant Pigment Made By Bacteria

Agomab bags $114 million in thriving regenerative medicine sector

The race to uncloak cancer with liquid biopsies

Series A Round Boosts Swedish Synthetic Biology Player by €6.4M

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!